Milestone Scientific (NYSE:MLSS) Receives New Coverage from Analysts at

Investment analysts at started coverage on shares of Milestone Scientific (NYSE:MLSSGet Rating) in a research note issued on Sunday. The firm set a “sell” rating on the stock.

Milestone Scientific Price Performance

MLSS opened at $0.81 on Friday. Milestone Scientific has a one year low of $0.71 and a one year high of $3.00. The company’s 50 day simple moving average is $0.99 and its 200-day simple moving average is $1.06. The stock has a market capitalization of $55.82 million, a P/E ratio of -6.75 and a beta of 1.37.

Milestone Scientific (NYSE:MLSSGet Rating) last released its quarterly earnings results on Tuesday, August 16th. The company reported ($0.04) EPS for the quarter. Milestone Scientific had a negative net margin of 85.20% and a negative return on equity of 53.11%. The company had revenue of $1.65 million for the quarter.

Milestone Scientific Company Profile

(Get Rating)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

Featured Articles

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.